| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,845,800 | 1,985,200 | 2,916,700 | 4,004,900 | | Cost of Revenue | 1,492,800 | 1,561,100 | 2,341,900 | 3,113,500 | | | Gross Profit | 353,000 | 424,100 | 574,800 | 891,400 | | | Operating Expenses | | Research Development | 52,800 | 52,300 | 80,100 | 88,100 | | Selling General and Administrative | 100,500 | 109,700 | 121,500 | 147,200 | | Non Recurring | (47,700) |
-
|
-
|
-
| | Others | 235,500 | 25,000 | 26,900 | 34,200 | | | | Total Operating Expenses | 341,100 |
-
|
-
|
-
| | | | Operating Income or Loss | 11,900 | 237,100 | 346,300 | 621,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,900 | 8,000 | 15,200 | 21,900 | | Earnings Before Interest And Taxes | 16,800 | 245,100 | 361,500 | 643,800 | | Interest Expense | (11,100) | 208,500 | 195,700 | 215,200 | | Income Before Tax | 27,900 | 36,600 | 165,800 | 428,600 | | Income Tax Expense | 1,400 | 10,300 | 52,700 | 129,600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 26,500 | 26,300 | 113,100 | 299,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 26,500 | 26,300 | 113,100 | 299,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $26,500 | $26,300 | $113,100 | $299,000 |
|
2.03% Nasdaq 0.00%
Income Statement
